openPR Logo
Press release

Kidney Cancer Diagnostics Market will Account for Around US$ 700 Mn Revenues by 2022

09-04-2017 10:30 AM CET | Health & Medicine

Press release from: Fact.MR

Kidney Cancer Diagnostics Market will Account for Around US$ 700

Fact.MR, in its latest research, anticipates the global kidney cancer diagnostics market to witness an impressive expansion at a CAGR of 6.4% over the forecast period 2017 to 2022.

Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies have been taken in active surveillance, renal biopsy, as well as minimally-invasive thermal ablation, on the back of surging diagnosis rate of the small renal masses, observed usually among individuals with high morbidity risks, undergoing operative treatment. These factors are expected to fuel growth of the global market for kidney cancer diagnostics.

Older population are most commonly affected by kidney cancer. Diagnosis of old-aged patients makes kidney cancer diagnostics an intricate chapter in the medical books. MRI and CT scan are staple diagnosis procedures in the global market for kidney cancer diagnostics, however, patients are anticipating the emergence of advanced and more effective diagnosis tests. Moreover, this urge to upgrade the diagnostic approach for kidney cancer patients is also resonated by medical organizations as they continue to direct heavy investments in research & developments of new diagnostic procedures. Improvements in early diagnosis tests have translated huge profits for market players, and these companies are also partnering with medical research organizations to develop diagnostic methods that can concurrently lower the maturation pace of tumor between multiples stages of kidney cancer.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56

9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market

Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.

Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.

Cancer research institutes will register the fastest expansion in the market during the forecast period.

Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=56

Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.

Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.

North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.

Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.

Competition Tracking

The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.

Click to View Complete Report @ https://www.factmr.com/report/56/kidney-cancer-diagnostics-market

About Us

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Office: Dublin 2
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-6111-593
( Dublin 2 )
Email: sales@factmr.com
Web: https://www.factmr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Cancer Diagnostics Market will Account for Around US$ 700 Mn Revenues by 2022 here

News-ID: 696603 • Views: 145

More Releases from Fact.MR

Automotive Lubricants Market: Opportunities, Growth Analysis and Forecast Assess …
The latest report by Fact.MR opines that automotive lubricants have witnessed plenty of developments in the past few years and have offered convenient enhancements. Over the forecast period, the market is set to witness a positive growth, and to gain remunerative momentum in emerging countries, thus giving an impetus to the automotive lubricants market. Moreover, a study conducted by the International Energy Agency (IEA) reveals that, by the end of
Spin-on Car Fuel Filters Market on track to record a modest CAGR of 2.8% and be …
The automobile industry is one of the most critical for any nation’s economic development which is why countries focus so much attention on it. Global carmakers have shifted their focus to emerging markets as the strong economic growth there has led to an increased desire for personal mobility. To get in-depth information view the report - https://www.factmr.com/report/136/car-fuel-filter-market With a number of emission scandals dominating headlines in the last few years,
04-15-2021 | Health & Medicine
Fact.MR
Prefilled Auto Injectors Market to surpass revenues worth US$ 3,616 Mn by the en …
The arrival of an array of cutting-edge biotech products coupled with the increasing preference for convenient injection of various therapeutic drugs is making a positive impact on the global market for prefilled auto-injectors. Demand for such injectors is anticipated to further escalate over the next couple of years. Self-inject procedures have become safer and convenient due to availability of advanced prefilled auto-injectors. Patient are increasingly putting their trust on prefilled
Aftermarket Car Air Filters Market to touch a value of nearly US$ 9,916 Million …
Global car air filter market is witnessing steady demand from all across the globe. This is due to the reason that car air filters are an integral part of the automobiles as they protect the internal combustion engine from dust particles and grime coming from the air that mixes with the fuel in the engine. If the air filter of a car is not clean, it may result in damage

All 5 Releases


More Releases for Cancer

Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,